Course Information

Incorporating the Canadian Dementia Guidelines into your Practice

Incorporating the Canadian Dementia Guidelines into your Practice

This CPD presents the updated diagnostic and treatment recommendations around Mild Cognitive Impairment (MCI), Vascular Cognitive Impairment (VCI), probable/possible Alzheimer’s Disease (AD), Rapidly Progressing Dementia (RPD,) and Early Onset Dementia (EOD). It also offers insight into areas such as neuroimaging and liquid biomarkers, while offering advice on how to discuss with your patients the recommendations around the use of these in Canada.

Upon completion of this CME, learners will be able to:

  • Demonstrate how to use the different criteria for the diagnosis of dementia, Mild Cognitive Impairment (MCI), Alzheimer’s Disease ( AD) and Vascular Cognitive Impairment (VCI) into their assessment of cognitive impairment;
  • Interpret current recommendations for medication use in the treatment of dementia, including (but not limited to) cholinesterase inhibitors, antipsychotics, and anti-depressants;
  • Define community and culturally appropriate resources which will support patients and their care partners;
  • Explain how to apply treatment and management strategies in their practice for dementia risk factors;
  • Identify when it is appropriate to engage a specialist referral for dementia;
  • Discuss effective communication techniques to use with patients and their care partners regarding the recommended appropriate use of neuroimaging and liquid biomarkers.



Course Registration

Incorporating the Canadian Dementia Guidelines into your Practice

MDcme (on behalf of its consortium partners) protects the privacy of personal and other information regarding course registrants. MDcme will not release personally identifiable information to a third party without an individual's consent, except such information as is required for reporting purposes to the body or bodies accrediting this course for continuing education study credits. MDcme collects and reviews all course data (registration/course completion statistics, pre/post-test and satisfaction survey) to determine if a course meets participants' learning needs. Data is reviewed to improve existing courses and to inform the development of future course offerings. If an evaluation report is provided to a third party, all data is summarized, with no participant identifying information included. Given the importance and potential impact of some courses, evaluation data may be presented and/or published in academic venues. Again, this data is always summarized, with no identifying information included.

At times, a contributing/partner organization involved in a course may request individual participant data from pre/post or evaluation surveys for quality improvement or educational research purposes. This data would be de-identified so would not be associated with any personally identifiable information such as your name, profession, city, etc.

If requested by a contributing/partner organization:

Do you consent to the release of your individual, de-identified pre/post or evaluation survey data for the purposes of quality improvement or educational research?


×

You must have an MDcme.ca account and be logged in to register for this course


Credits


Expiry Date

This course expires on
Sunday, January 19, 2014


  • Carl Fournier, MD, MCFP
  • Graeme Bethune, MD, CCFP, FCFP, CDE
  • Lydia Hatcher, MD, CCFP, FCFP, CAPM